Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM)
Publication
, Conference
Goel, N; Soler-Ferran, D; Coutreau, M; Escobar, J; Courtemanche, K; Needham, M; Greenberg, S
Published in: ARTHRITIS & RHEUMATOLOGY
2021
Duke Scholars
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
2021
Volume
73
Start / End Page
4098 / 4100
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Goel, N., Soler-Ferran, D., Coutreau, M., Escobar, J., Courtemanche, K., Needham, M., & Greenberg, S. (2021). Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM). In ARTHRITIS & RHEUMATOLOGY (Vol. 73, pp. 4098–4100).
Goel, Niti, Dulce Soler-Ferran, Monette Coutreau, Jorge Escobar, Kate Courtemanche, Merrilee Needham, and Steven Greenberg. “Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM).” In ARTHRITIS & RHEUMATOLOGY, 73:4098–4100, 2021.
Goel N, Soler-Ferran D, Coutreau M, Escobar J, Courtemanche K, Needham M, et al. Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM). In: ARTHRITIS & RHEUMATOLOGY. 2021. p. 4098–100.
Goel, Niti, et al. “Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM).” ARTHRITIS & RHEUMATOLOGY, vol. 73, 2021, pp. 4098–100.
Goel N, Soler-Ferran D, Coutreau M, Escobar J, Courtemanche K, Needham M, Greenberg S. Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM). ARTHRITIS & RHEUMATOLOGY. 2021. p. 4098–4100.
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
2021
Volume
73
Start / End Page
4098 / 4100
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences